Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FSTA3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,670
Award facts
- Contract value 100% obligated
- $29,669.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $29,669.58 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on August 21, 2025, for the supply of Entyvio 300 mg vials, with an ultimate completion date of September 12, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its headquarters location. This delivery order was issued without set-aside designation, leveraging the contractor's competitive position as a certified woman-owned small business in federal procurement markets.
This award represents a delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency, valued at $499,999,999 and valid through November 2026. The parent IDC enables the agency to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support medical supply needs across Department of Defense healthcare facilities worldwide. Entyvio, a biologic medication used in the treatment of inflammatory bowel diseases, represents one component of the contractor's extensive pharmaceutical portfolio supporting military health system requirements.
Quick answers
Who was awarded contract SPE2DB25FSTA3?
SPE2DB25FSTA3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 21, 2025.
How much is contract SPE2DB25FSTA3 worth?
The government has obligated $29,670 on SPE2DB25FSTA3.
Is contract SPE2DB25FSTA3 an order under another contract?
Yes. SPE2DB25FSTA3 is a delivery order under SPE2DB22D9304, an indefinite delivery contract.
Was contract SPE2DB25FSTA3 competed?
The extent of competition for SPE2DB25FSTA3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award